Quarterly report pursuant to Section 13 or 15(d)

Stock Options and Restricted Stock Units

v3.10.0.1
Stock Options and Restricted Stock Units
6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options and Restricted Stock Units

NOTE 10 – STOCK OPTIONS AND RESTRICTED STOCK UNITS

 

On July 31, 2014, the Board of Directors of Q2P approved the Founders Stock Option Plan (“Founders Plan”) and the 2014 Employee Stock Option Plan (the “2014 Plan”), collectively the “Option Plans”. The Option Plans were developed to provide a means whereby directors and selected employees, officers, consultants, and advisors of the Company may be granted incentive or non-qualified stock options to purchase restricted common stock of the Company. On February 25, 2016, to accommodate the appointment of new Board members and additional incentive stock options and stock grants to key employees of the Company, the Board approved the 2016 Omnibus Equity Incentive Plan (“2016 Plan”), which allowed for an additional 4 million shares of common stock, stock options, stock rights (restricted stock units), or stock appreciation rights to be granted by the Board in its discretion.

 

In June 2018, the Company issued a total of 1,600,000 common stock options under the 2016 Plan to three independent Board members and one Board observer. The options vest one-half immediately and the balance in 6 months, with a 10-year term and exercisable at $0.10 per share. The options were valued at $64,440 (pursuant to the Black Scholes valuation model, and as shown in the table detailing the calculation of fair value below), based on an exercise price of $0.10 per share and with a maturity life of 3.0 years.

 

For the six months ended June 30, 2018, the charge to the consolidated statements of operations for the amortization of stock option grants awarded under the Option Plans and 2016 Plan and for warrants was $96,849.

 

A summary of the common stock options issued under the Option Plans and the 2016 Plan for the period from December 31, 2017 through June 30, 2018 follows:

 

    Number Outstanding    

Weighted

Avg. Exercise Price

   

Weighted

Avg. Remaining Contractual Life (Years)

 
Balance, December 31, 2017     6,915,480     $ 0.21       5.6  
Options issued     1,600,000       0.10       9.8  
Options exercised                  
Options cancelled                  
Balance, June 30, 2018     8,515,480     $ 0.19       6.0  

 

The vested and exercisable options at period end follows:

 

   

Exercisable/

Vested

Options Outstanding

   

Weighted Avg.

Exercise Price

   

Weighted

Avg.

Remaining Contractual

Life (Years)

 
Balance, June 30, 2018     7,672,147     $ 0.20       5.6  
                         

 

The fair value of new stock options and warrants granted using the Black-Scholes option pricing model was calculated using the following assumptions:

 

   

Six Months

June 30, 2018

 
Risk free interest rate     2.61 %
Expected volatility     131.4 %
Expected dividend yield     0 %
Expected term in years     3.0  
Average value per options   $ 0.04  

 

Expected volatility is based on historical volatility of the Company’s own common stock. Short Term U.S. Treasury rates were utilized as the risk free interest rate. The expected term of the options was calculated using the alternative simplified method codified as ASC 718 “Accounting for Stock Based Compensation,” which defined the expected life as the average of the contractual term of the options and the weighted average vesting period for all issuances.